Ayala is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers.We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers. Our focus is on inhibiting the Notch activating pathway with potentially best in class gamma secretase inhibitors (GSIs...
Ayala is a clinical stage precision oncology company dedicated to developing targeted therapies for genomically defined, clinically underserved cancers.We look to target rare and unique cancers, in which the Notch activation pathway has been dysregulated. Notch is a proven oncogenic driver in defined cancers. Our focus is on inhibiting the Notch activating pathway with potentially best in class gamma secretase inhibitors (GSIs).
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.